Insurance Coverage for Obesity Drugs is Shrinking
For millions of Americans managing obesity and type 2 diabetes, the arrival of GLP-1 receptor agonists—such as semaglutide and tirzepatide—marked a clinical breakthrough. However, the financial … Read more